Intrapericardial Paclitaxel Delivery Inhibits Neointimal Proliferation and Promotes Arterial Enlargement After Porcine Coronary Overstretch
- 26 September 2000
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 102 (13) , 1575-1581
- https://doi.org/10.1161/01.cir.102.13.1575
Abstract
Background—Catheter-based intrapericardial (IPC) delivery of therapeutic agents has recently been demonstrated. Paclitaxel is known to inhibit vascular smooth muscle cell proliferation. This study ...Keywords
This publication has 11 references indexed in Scilit:
- Review: Clinical aspects of vascular remodeling.Journal of Cardiovascular Electrophysiology, 1999
- Persistent primary coronary dilation induced by transatrial delivery of nitroglycerin into the pericardial space: a novel approach for local cardiac drug deliveryJournal of the American College of Cardiology, 1999
- Initial clinical experience with perducer® device: Promising new tool in the diagnosis and treatment of pericardial diseaseClinical Cardiology, 1999
- Pharmacokinetics and consistency of pericardial delivery directed to coronary arteries: Direct comparison with endoluminal deliveryClinical Cardiology, 1999
- Minimally invasive access of the normal pericardium: Initial clinical experience with a novel deviceClinical Cardiology, 1999
- Efficient in vivo catheter-based pericardial gene transfer mediated by adenoviral vectorsClinical Cardiology, 1999
- Paclitaxel selectively induces mitotic arrest and apoptosis in proliferating bovine synoviocytesArthritis & Rheumatism, 1997
- AbstractJournal of the American College of Cardiology, 1997
- Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat.Journal of Clinical Investigation, 1995
- Histologic Changes of Doxycycline Pleurodesis in RabbitsChest, 1994